A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)

Clinical trial NCT05137847 · COMPLETED

Trial details

NCT number: NCT05137847
Sponsor: Eisai Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Lymphoma, T-cell, Peripheral Lymphoma, T-cell, Cutaneous

Start date: 2021-05-24
Primary completion: 2023-03-17
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.